与激素结合的GLP-1受体的晶体结构
Ali Jazayeri1, Mathieu Rappas1, Alastair J H Brown1
1Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK.
研究人员确定了与激素结合的葡萄糖类1 (GLP-1) 受体的晶体结构. 这种结构洞察力指导了治疗糖尿病的新型激动剂的设计.
科学领域:
- 生物化学
- 结构生物学
- 药理学
背景情况:
- 葡萄糖类1 (GLP-1) 通过胰岛素调节对葡萄糖平衡至关重要.
- GLP- 1激动剂是糖尿病的有效治疗方法.
- 了解GLP-1作用的分子机制是药物开发的关键.
研究的目的:
- 阐明GLP-1作用的分子机制.
- 确定与截断的激素结合的全长GLP-1受体的晶体结构.
主要方法:
- 使用X射线结晶学来确定GLP-1受体-复合物的结构.
- 新型激剂的结构导向设计.
主要成果:
- 晶体结构显示激剂在受体结合口袋中采用了α-螺旋形状.
- 通过膜螺旋的排列表明有活跃的受体构造.
- 在糖尿病小鼠模型中,设计的激动剂表现出强烈的活体活性.
结论:
- 确定的结构为GLP-1受体激活提供了分子洞察力.
- 结构信息对于设计基于GLP-1的改善疗法是有价值的.
- 这项工作有助于开发新的糖尿病治疗方法.
更多相关视频
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
G-protein Coupled Receptors
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
